Want to see TSE:FRX full AI Analyst Report?

Fennec Pharmaceuticals (FRX) Financial Statements

39 Followers

Fennec Pharmaceuticals Financial Overview

Fennec Pharmaceuticals's market cap is currently C$527.74M. The company's EPS TTM is C$-0.3071; its P/E ratio is -34.84; Fennec Pharmaceuticals is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is C$0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 44.64M	$ 47.54M	$ 21.25M	$ 1.53M	$ 0.00
Gross Profit	$ 40.88M	$ 44.35M	$ 19.99M	$ 1.45M	$ 0.00
Operating Income	$ -6.35M	$ 2.48M	$ -13.06M	$ -22.74M	$ -17.22M
EBITDA	$ -7.45M	$ 4.80M	$ -12.36M	$ -22.59M	$ -17.22M
Net Income	$ -9.74M	$ -436.00K	$ -16.05M	$ -23.71M	$ -17.35M
Balance Sheet
Cash & Short-Term Investments	$ 36.72M	$ 26.63M	$ 13.27M	$ 23.77M	$ 21.10M
Total Assets	$ 70.07M	$ 44.95M	$ 26.86M	$ 26.94M	$ 22.41M
Total Debt	$ 0.00	$ 19.34M	$ 30.95M	$ 24.90M	$ 4.99M
Net Debt	$ -36.72M	$ -7.29M	$ 17.68M	$ 1.13M	$ -16.11M
Total Liabilities	$ 35.02M	$ 50.82M	$ 38.49M	$ 29.51M	$ 6.64M
Stockholders' Equity	$ 35.05M	$ -5.87M	$ -11.62M	$ -2.57M	$ 15.77M
Cash Flow
Free Cash Flow	$ -12.47M	$ 26.98M	$ -17.14M	$ -18.06M	$ -14.22M
Operating Cash Flow	$ -12.47M	$ 26.98M	$ -17.14M	$ -18.06M	$ -14.22M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 22.63M	$ -13.62M	$ 6.64M	$ 20.73M	$ 4.98M

Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Income Statement >

Fennec Pharmaceuticals Debt to Assets

Balance Sheet >

Fennec Pharmaceuticals Cash Flow

Cash Flow >

Fennec Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >